Category: Washington Post

Rising cases in Southeast could be start of U.S. RSV season, CDC warns

The CDC urged medical professionals to prepare to use the new treatments approved this year for RSV, the leading cause of hospitalization among U.S. infants.

Narcan is now for sale without a prescription. Here’s what to know.

The nasal spray reverses opioid overdoses. More than 110,000 people are believed to have died of drug poisonings last year, many from synthetic opioids.

Evening workouts can give you health benefits, including better sleep

If morning exercise doesn’t work with your schedule, getting some evening exercise may be your best bet. And it shouldn’t hurt your shut-eye if done correctly.

Study links 1-year-olds’ screen time with developmental delay risks

As screen time increased, so did the likelihood of developmental delays, primarily in communication and problem-solving skills, the study found.

What patients — and doctors — should know about ‘benzo’ withdrawal

There is little awareness about the consequences of withdrawing from long-term use or high doses of Xanax, Klonopin, Ativan and Valium.

More unpaid work — the hidden cost to moms of their kids’ online lives

The burden of “unpaid digital care work” was “intense, constant and unyielding, and it takes a physical and emotional toll on mothers,” a small study found.

CDC warns doctors to look out for rare, deadly flesh-eating bacteria

The CDC said many infections from Vibrio vulnificus — which has killed at least 13 this year — are acquired after an open wound is exposed to warm coastal waters.

Possible easing of marijuana restrictions could have major implications

The drug could gain wider acceptance as a medical treatment and pot businesses could see their bottom line boosted.

Lawrence Lacks Sr., whose mother’s cells were taken without consent, dies at 88

His mother, Henrietta Lacks, was a Black mother of five dying of cancer when her cells were extracted without her knowledge and later used in medical experiments.

In the Gulf, a growing scramble for Ozempic and other weight-loss drugs

A new class of weight loss drugs are surging in popularity in the oil-rich Persian Gulf, leading to shortages and calls for greater regulation.